These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38235548)

  • 1. The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.
    Wu Z; Huang K; Bao S; Zhang X; Li J; Kong W; Shi Y; Xie Y
    Scand J Gastroenterol; 2024 May; 59(5):561-569. PubMed ID: 38235548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters.
    Xue Y; Xu J; Li M; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():951689. PubMed ID: 36120429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of Insulin Resistance Indices for Identifying Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han AL; Lee HK; Shin SR
    Metab Syndr Relat Disord; 2024 Jun; 22(5):402-409. PubMed ID: 38574322
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.
    Chen Q; Hu P; Hou X; Sun Y; Jiao M; Peng L; Dai Z; Yin X; Liu R; Li Y; Zhu C
    Cardiovasc Diabetol; 2024 Jul; 23(1):232. PubMed ID: 38965572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
    Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
    Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
    BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and Anthropometric Indices of Insulin Resistance in Obese and Overweight Children with Metabolic Dysfunction-Associated Fatty Liver Disease.
    Trochimczyk K; Flisiak-Jackiewicz M; Bobrus-Chociej A; Lebensztejn A; Wojtkowska M; JamioĊ‚kowski J; Lebensztejn DM
    Med Sci Monit; 2024 Jul; 30():e943375. PubMed ID: 38956840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.
    He X; Huang X; Qian Y; Sun T
    Front Endocrinol (Lausanne); 2023; 14():1188214. PubMed ID: 37484966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults.
    Li H; Zhang Y; Luo H; Lin R
    Front Endocrinol (Lausanne); 2022; 13():977625. PubMed ID: 36407325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease.
    Min Y; Wei X; Wei Z; Song G; Zhao X; Lei Y
    Cardiovasc Diabetol; 2024 Jun; 23(1):188. PubMed ID: 38824550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults.
    Peng H; Pan L; Ran S; Wang M; Huang S; Zhao M; Cao Z; Yao Z; Xu L; Yang Q; Lv W
    Front Endocrinol (Lausanne); 2023; 14():1083032. PubMed ID: 36742412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between different triglyceride glucose index-related obesity indices and periodontitis: results from NHANES 2009-2014.
    Yang L; Fang S; Zhang R; Xia R
    Lipids Health Dis; 2024 Jul; 23(1):213. PubMed ID: 38970059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between triglyceride glucose index-related indices with gallstone disease among US adults.
    Fu C; Li X; Wang Y; Chen J; Yang Y; Liu K
    Lipids Health Dis; 2024 Jun; 23(1):203. PubMed ID: 38937793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the appropriate cutoff points for anthropometric indices and their relationship with cardio-metabolic indices to predict the risk of metabolic associated fatty liver disease.
    Hosseini SA; Alipour M; Sarvandian S; Haghighat N; Bazyar H; Aghakhani L
    BMC Endocr Disord; 2024 Jun; 24(1):79. PubMed ID: 38834991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the triglyceride-glucose index and its related parameters with frailty.
    Yin H; Guo L; Zhu W; Li W; Zhou Y; Wei W; Liang M
    Lipids Health Dis; 2024 May; 23(1):150. PubMed ID: 38773587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
    Khamseh ME; Malek M; Jahangiri S; Nobarani S; Hekmatdoost A; Salavatizadeh M; Soltanieh S; Chehrehgosha H; Taheri H; Montazeri Z; Attaran F; Ismail-Beigi F; Alaei-Shahmiri F
    Dig Dis Sci; 2024 Apr; 69(4):1430-1443. PubMed ID: 38438774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Zhang F; Han Y; Wu Y; Bao Z; Zheng G; Liu J; Li W
    Ann Med; 2024 Dec; 56(1):2409342. PubMed ID: 39348274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.
    Malek M; Khamseh ME; Chehrehgosha H; Nobarani S; Alaei-Shahmiri F
    Endocrine; 2021 Dec; 74(3):538-545. PubMed ID: 34355342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome.
    Wei X; Min Y; Song G; Ye X; Liu L
    Cardiovasc Diabetol; 2024 Apr; 23(1):134. PubMed ID: 38658993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.